A. Witor

Long‐term trends in HIV care entry: over 15 years of clinical experience from Poland

A. Horban, E. Firląg-Burkacka, B. Szetela, 2019, HIV medicine.

Meeting the WHO 90% target: antiretroviral treatment efficacy in Poland is associated with baseline clinical patient characteristics

A. Szymczak, A. Horban, B. Szetela, 2017, Journal of the International AIDS Society.

The role of nevirapine in the antiretroviral therapy

B. Szetela, M. Leszczyszyn‐Pynka, E. Jabłonowska, 2008 .

Circulation of HIV-1 A6 variant in the East border of European Union - dynamics of the virus transmissions between Poland and Ukraine.

A. Urbańska, A. Chaillon, B. Szetela, 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Molecular epidemiology and HIV-1 variant evolution in Poland between 2015 and 2019

A. Urbańska, A. Kalinowska-Nowak, M. Parczewski, 2021, Scientific Reports.

Metabolic abnormalities and cardiovascular risk in HIV-infected cohort of patients treated with protease inhibitors

R. Flisiak, J. Gąsiorowski, A. Grzeszczuk, 2015 .

Clinical Perspective on Human Immunodeficiency Virus Care of Ukrainian War Refugees in Poland.

A. Szymczak, B. Szetela, A. Kalinowska-Nowak, 2023, Clinical Infectious Diseases.

[Occupational exposure to HIV in health care workers, Silesia voivodeship].

J. Zejda, M. Kowalska, B. Braczkowska, 2010, Medycyna pracy.

Retrospective analysis of the HIV-1 reverse transcriptase inhibitors’ resistance in Silesia, Poland

Tomasz J. Wąsik, J. Bratosiewicz-Wąsik, Piotr Kruszyński, 2011, Medical science monitor : international medical journal of experimental and clinical research.

Phylodynamic evolution of HIV-1 A6 sub-subtype epidemics in Poland.

A. Urbańska, B. Szetela, M. Parczewski, 2024, Journal of medical virology.